Ramipril
62 NDCs across 8 manufacturers|62 Generic,0 Brand
Ramipril is used to treat diabetic nephropathies, heart failure, hypertension and left ventricular dysfunction, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Jan 28, 1991, and the first generic was approved Oct 24, 2005. FDA's Orange Book lists 31 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $18 million on Ramipril across 1.5 million claims for 378,000 beneficiaries.
Ramipril is available as 62 NDCs from 8 manufacturers (62 generic, 0 brand), with NADAC prices from $0.05 to $0.18 per EA — the most expensive product costs about 3.9× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
62
62G / 0B
Manufacturers
8
competing in market
Price Spread
$0.05 – $0.18
per EA
7d Activity
avg -2.2% WoW · of 62 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Lupin Pharmaceuticals Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Angiotensin Converting Enzyme Inhibitor class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
8 manufacturers producing RAMIPRIL
Frequently Asked Questions
What is Ramipril used to treat?
Ramipril is used to treat diabetic nephropathies, heart failure, hypertension and left ventricular dysfunction, per the National Library of Medicine's MED-RT classification.
When did Ramipril become available as a generic?
FDA approved the first generic Ramipril (ANDA) on Oct 24, 2005. The Orange Book currently lists 31 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Ramipril?
In 2024, Medicare Part D spent $18 million on Ramipril across 1.5 million claims for 378,000 beneficiaries.
How many Ramipril products are on the market?
The Ramipril drug market contains 62 NDCs from 8 manufacturers — 62 generic and 0 brand products.
What is the price range for Ramipril?
NADAC reference prices for Ramipril range from $0.0460 to $0.1792 per EA — the most expensive product costs about 3.9× the cheapest.
Which manufacturers make Ramipril?
8 manufacturers list Ramipril in NADAC. Ranked by number of NDCs, the largest are Lupin Pharmaceuticals Inc. (12), Hikma Pharmaceuticals USA Inc. (9), Aurobindo Pharma Limited (8), Chartwell RX LLC (8), Rising Pharma Holdings Inc. (8).
How has the price of Ramipril changed recently?
Over the past 7 days, 12 Ramipril NDCs rose and 35 fell, with a market-wide average change of -2.2%.